Journal of Leukocyte Biology · 2001 · 41 citations · 35 references
Veterinary MedicineImmunologyPharmacologyImmunopharmacologyImmunophysiologyInflammationInflammatory MediatorsLeukocyte RecruitmentNeutrophil BiologyChemotactic SignalingMonocyte Chemoattractant Protein-1
Endothelin (ET)-1(1-31) is a novel 31-amino acid-length peptide derived from big ET-1 by chymase or other chymotrypsin-type proteases and is a major ET derivative in human neutrophils. In this study, we revealed that ET-1(1-31), but not big ET, exhibited chemotactic activities toward human neutrophils and monocytes as an inflammatory mediator, although the effects were less potent than those of formyl-methionyl-leucyl-phenylalanine or interleukin-8. However, the chemotactic effects of ET-1(1-31) were much greater than those of the 21-amino acid ET-1, ET-1(1-21). Checkerboard analyses revealed that the effects are chemotactic rather than chemokinetic. The effects of ET-1(1-31) are not mediated by interleukin-8 or monocyte chemoattractant protein-1. The chemotactic effects and an increase in intracellular-free Ca(2)(+) caused by ET-1(1-31) were significantly inhibited by BQ123, an ET(A) receptor antagonist, but not by BQ788, an ET(B) receptor antagonist, suggesting that ET-1(1-31) mediates chemotaxis through an ET(A) or ET(A)-like receptor.
35
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Masashi Yanagisawa, Hiroki Kurihara, Sadao Kimura et al. · Nature · 1988 · 10.8K citations · Full text
Cloning and expression of a cDNA encoding an endothelin receptor
Hiroshi Arai, Seiji Hori, Ichiro Aramori et al. · Nature · 1990 · 2.6K citations
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
Takeshi Sakurai, Masashi Yanagisawa, Yoh Takuwat et al. · Nature · 1990 · 2.4K citations · Full text
Dong Xu, Noriaki Emoto, Adel Giaid et al. · Cell · 1994 · 930 citations